Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development
Clinical and Translational Science · 2026-11 · 19 (11)
DOI: 10.1111/cts.70769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 01.11.2026. Verfasst von Paridhi Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology, Bristol Myers Squibb, Princeton, New Jersey, USA. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Pharmacology, Bristol Myers Squibb, Princeton, New Jersey, USA.
ORCID-Profile: Paridhi Gupta, Zheyi Hu, Li Zhu, Lora Hamuro
Zitieren
APA
Gupta, P., Hu, Z., Zhu, L., & Hamuro, L. (2026). Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development. Clinical and Translational Science, 19(11). https://doi.org/10.1111/cts.70769
Vancouver
Gupta P, Hu Z, Zhu L, Hamuro L. Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development. Clinical and Translational Science. 2026;19(11). doi:10.1111/cts.70769
BibTeX
@article{Gupta2026,
author = {Gupta, Paridhi and Hu, Zheyi and Zhu, Li and Hamuro, Lora},
title = {Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development},
journal = {Clinical and Translational Science},
year = {2026},
volume = {19},
number = {11},
doi = {10.1111/cts.70769}
}
EUVIMED